Creative Bioarray Launches Autophagy Detection Services to Support Cell Growth and Development

January 31 20:21 2023
Creative Bioarray announced the release of its autophagy detection services to support cell growth and development.

New York, USA – January 31, 2023 – Cell Assay platform, the division of Creative Bioarray, is an innovative biotechnology company whose mission focuses on developing unique technologies that provide global scientists with high-quality products and satisfactory services to facilitate the investigation of life science research. With a professional cell biology research platform, Creative Bioarray focuses on cell growth and cell death research such as cell proliferation, apoptosis, migration, necrosis, autophagy, ferroptosis, and pyroptosis. Recently, Creative Bioarray announced the release of its autophagy detection services to support cell growth and development.

The existing autophagy detection methods are mainly divided into in vitro detection (including static detection and dynamic detection) and in vivo detection. Static detection methods focus on detecting the existence of autophagy, and dynamic detection methods focus on detecting the complete process of autophagy. In vivo testing allows the observation of results directly in animals. Relying on professional technology and detection platform, Creative Bioarray can provide autophagy detection services for researchers. Normal cultured cells can observe and detect the autophagy process after being intervened by autophagy inducers or inhibitors.

Creative Bioarray’s experienced scientists can complete various tests efficiently and accurately to ensure that the experimental data is accurate and reliable. In addition, Creative Bioarray has advanced fluorescence microscopy and flow cytometry systems, which can provide customers with high-quality imaging technology and improve research results.

Creative Bioarray has been committed to the research of cell biology technology for many years. Based on advanced technical equipment and complete platform construction, it can provide customers with a variety of reliable autophagy detection services. Creative Bioarray uses electron microscopy to view samples and determine the presence of autophagic bubble structures. Under the electron microscope, damaged organelles such as mitochondrial swelling and degeneration can be observed in autophagic cells. There is a bubble-like double-membrane structure around it, or a double-membrane surrounds the mitochondria to form an autophagosome. Residues that cannot be degraded in lysosomes can also be observed in autophagic cells.

Creative Bioarray has developed a series of autophagy research technologies, which can undertake various types of autophagy detection, and can provide a full set of customized technical services such as cell culture, cell processing, image acquisition, and data measurement.

“With rich operating experience and superb technology, we provide detection reagents with high sensitivity and specificity.” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “We provide a variety of apoptosis detection methods to meet the individual scientific research needs of customers.”

About Creative Bioarray

Creative Bioarray is dedicated to offering customers innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house expert support, Creative Bioarray has already countenanced research all around the world.

Media Contact
Company Name: Creative Bioarray
Contact Person: Hannah Cole
Email: Send Email
Phone: 1-631-386-8241
Country: United States